SHI
SV Health Investors Portfolio holdings
AUM $32.3M
1-Year Return
20.15%
This Quarter Return
+29.26%
1 Year Return
-20.15%
3 Year Return
+90.94%
5 Year Return
+318.05%
10 Year Return
–
AUM
$170M
AUM Growth
+$8.04M
(+5%)
Cap. Flow
-$39.4M
Cap. Flow
% of AUM
-23.12%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
KalVista Pharmaceuticals
KALV
|
+$20.5M |
| 2 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
+$17.8M |
| 3 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
+$1.14M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
KalVista Pharmaceuticals
KALV
$696M
| $52.4M | 30.75% |
1,831,548
-716,654
| -28% | -$20.5M |
|
|
TECX
2
Tectonic Therapeutic, Inc. Common Stock
TECX
$315M
| $42.6M | 24.97% |
160,892
-67,110
| -29% | -$17.8M |
|
|
DCPH
3
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $28.7M | 16.86% |
1,238,198
-49,029
| -4% | -$1.14M |
|
4
Sutro Biopharma
STRO
$75.4M
| $20.8M | 12.19% |
1,824,542
| – | – |
|
|
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
| $15.8M | 9.26% |
510,141
| – | – |
|
6
X4 Pharmaceuticals
XFOR
$68.9M
| $5.42M | 3.18% |
10,383
| – | – |
|
7
Ocular Therapeutix
OCUL
$2.18B
| $2.49M | 1.46% |
628,236
| – | – |
|
8
Astria Therapeutics
ATXS
$425M
| $2.26M | 1.33% |
47,628
| – | – |
|
|
ETRM
9
DELISTED
EnteroMedics Inc.
ETRM
| – | – |
-1,072
| Closed | – |
|